QJ ANTIINFECTIVES FOR SYSTEMIC USE
QJ05 ANTIVIRALS FOR SYSTEMIC USE
QJ05A DIRECT ACTING ANTIVIRALS
QJ05AP Antivirals for treatment of HCV infections
QJ05AP56 sofosbuvir, velpatasvir and voxilaprevir
Last updated: 2024-01-17
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer